Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Boston Life Sciences receives notice of patent allowance for CNS growth factor

June 16, 1997

BMS-180048 vs. placebo for acute treatment of migraine

June 16, 1997

Melatonin evaluated in emergency physicians on the night shift

June 13, 1997

Gensia receives FDA approval of ANDA for atracurium besilate

June 13, 1997

Carvedilol and its metabolite attenuate Hb-mediated neuronal injury

June 13, 1997

Chiral TNF inhibitors reported by Schering AG

June 11, 1997

Physostigmine improves working memory and alters neural activity in volunteers

June 10, 1997

Protein repair enzyme may be involved in seizures/neurodegenerative diseases

June 10, 1997

Janssen prepares lubelozole N-oxides

June 10, 1997

P&U discloses inhibitors of enzyme involved in neurodegenerative diseases

June 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...